PIOLAX (5988) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
16 Mar, 2026Executive summary
FY25 continues to face a challenging business environment, with decreased revenue and profit in the first half compared to the previous year, but results are roughly in line with the plan.
Net sales for the six months ended September 30, 2025, decreased by 5.9% year-over-year to ¥30,060 million.
Operating profit dropped 33.5% year-over-year to ¥845 million, and profit attributable to owners of parent fell 64.5% to ¥435 million.
Strategic focus on product development, organizational restructuring, and productivity improvements, including the new Moka Plant and a reform promotion project.
Regional strategies emphasize sales expansion in North America, China, and India, with investments in new plants and enhanced local operations.
Financial highlights
FY25 sales forecast at ¥620 billion, down from ¥633 billion in FY24; operating profit forecast at ¥21 billion, down from ¥23 billion.
1H FY25 sales at ¥300 billion, down ¥19 billion year-over-year; operating profit at ¥8.4 billion, down ¥4.2 billion.
Net profit for 1H FY25 at ¥4.4 billion, down ¥7.9 billion year-over-year.
Gross profit for the period was ¥6,606 million, down from ¥7,310 million year-over-year.
Ordinary profit declined 56.4% year-over-year to ¥787 million.
Outlook and guidance
Full-year net sales forecast for FY ending March 31, 2026, is ¥62,000 million, a 2.1% decrease year-over-year.
Operating profit is projected at ¥2,100 million (down 11.9%), and profit attributable to owners of parent at ¥1,200 million (down 33.1%).
Targeting ROE of 8% or higher by FY27.
Sales expected to recover to ¥660 billion in FY26 and ¥690 billion in FY27, with operating profit rising to ¥46 billion and ¥63 billion, respectively.
Annual dividend forecast remains unchanged at ¥92.00 per share.
Latest events from PIOLAX
- Sales up 3.2% but profits down; focus on CASE, global growth, and capital returns.5988
Q2 202516 Mar 2026 - Profits and sales fell sharply, but long-term growth targets and strong shareholder returns remain.5988
Q4 202516 Mar 2026 - Sales rose but profits fell on higher costs; full-year profit forecast remains lower.5988
Q1 202516 Mar 2026 - Net income fell 52% year-over-year as sales and profitability declined, with guidance unchanged.5988
Q3 202516 Mar 2026 - Profits and comprehensive income fell sharply, with a cautious outlook for the full year.5988
Q1 202616 Mar 2026 - Profits and comprehensive income fell sharply, but a moderate recovery is forecasted.5988
Q3 202616 Mar 2026